We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EURK:NASDAQEureka Acquisition Corp Analysis

Data as of 2026-07-10 - not real-time

$12.44

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Eureka Acquisition Corp is trading at $12.44, comfortably above its 20‑day SMA (≈$11.67) and 50‑day SMA (≈$11.53), indicating a short‑term bullish bias. The MACD shows a bullish signal with the line above the signal, while the RSI sits near 74, placing the stock in overbought territory and suggesting a potential pull‑back. Volume has been decreasing and the 30‑day volatility is high at over 23%, which amplifies short‑term price swings. The beta is essentially neutral (≈‑0.02), meaning market moves have little impact, but the thin trading volume and small market cap (~$27 M) create liquidity risk. Fundamentally, the company reports zero revenue, negative book value (P/B ≈‑29), and a sizable debt load of $1.9 B against modest cash of $0.15 M, making the current price appear disconnected from underlying assets. The recent announcement of a dividend from “excess cash” is not sustainable given the negative cash flows and high debt. Overall, technicals suggest a short‑term rally may be exhausted, while the lack of operating performance and deteriorating fundamentals point to a bearish longer‑term outlook.
Investors should weigh the speculative nature of a shell‑company SPAC, the overbought technical condition, and the unsustainable dividend claim before deciding on exposure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • RSI in overbought zone
  • Decreasing volume trend
  • Proximity to resistance at $14.28

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD but weak fundamentals
  • Neutral beta limiting market‑driven moves
  • Uncertain outcome of any merger or business combination

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Zero revenue and negative book value
  • High debt relative to cash
  • Unsustainable dividend claim

Key Metrics & Analysis

Financial Health

ROA-1.43%
P/B Ratio-29.1
Op. Cash Flow$-753140
Free Cash Flow$-354844
Industry P/E17.6

Technical Analysis

TrendBullish
RSI74.0
Support$11.06
Resistance$14.28
MA 20$11.67
MA 50$11.53
MA 200$11.15
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta-0.02
Volatility23.47%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.